ADVERTISEMENT

Piramal Pharma - Work-In-Progress To Address Challenges In The CDMO Segment: Motilal Oswal

While there are near-term headwinds in its CDMO business, the outlook remains interesting.

<div class="paragraphs"><p>Close view of holding capsules. (Photo: freepik)</p></div>
Close view of holding capsules. (Photo: freepik)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit